Concord Biotech Limited

Concord Biotech Limited (CONCORDBIO) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

concordbiotech.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-09-03

Stock price
₹1447.70
Market cap
15,349 Cr
Stock P/E
56.1
P/B
7.54
Dividend yield
0.7%

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales262 Cr241 Cr319 Cr216 Cr310 Cr244 Cr430 Cr204 Cr247 Cr278 Cr326 Cr257 Cr
Operating expenses (approx.)143 Cr135 Cr185 Cr135 Cr174 Cr146 Cr239 Cr143 Cr159 Cr179 Cr208 Cr175 Cr
EBITDA119 Cr106 Cr134 Cr81 Cr137 Cr98 Cr190 Cr61 Cr88 Cr99 Cr119 Cr82 Cr
OPM %45.4%44.0%42.1%37.7%44.1%40.1%44.3%30.1%35.8%35.6%36.4%32.0%
Other income8 Cr8 Cr11 Cr10 Cr10 Cr15 Cr9 Cr14 Cr13 Cr10 Cr15 Cr13 Cr
Interest0.84 Cr0.50 Cr0.46 Cr0.24 Cr0.10 Cr0.10 Cr0.10 Cr0.06 Cr0.06 Cr0.08 Cr0.08 Cr0.04 Cr
Depreciation13 Cr14 Cr14 Cr13 Cr13 Cr13 Cr15 Cr18 Cr18 Cr19 Cr20 Cr18 Cr
Profit before tax113 Cr103 Cr129 Cr80 Cr130 Cr101 Cr184 Cr59 Cr86 Cr86 Cr114 Cr78 Cr
Tax %25.3%24.8%26.2%25.1%26.5%24.9%23.5%25.0%26.4%26.1%22.4%26.4%
Net profit81 Cr78 Cr95 Cr60 Cr96 Cr76 Cr140 Cr44 Cr63 Cr64 Cr88 Cr58 Cr
EPS (₹)₹7.74₹7.41₹9.08₹5.70₹9.15₹7.26₹13.42₹4.21₹6.03₹6.08₹8.46₹5.52

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2024Mar 2025Mar 2026TTM
Sales1,017 Cr1,200 Cr1,055 CrSign in for TTM
Operating expenses (approx.)585 Cr694 Cr687 CrSign in for TTM
EBITDA432 Cr506 Cr367 CrSign in for TTM
OPM %42.4%42.2%34.8%Sign in for TTM
Other income34 Cr44 Cr52 CrSign in for TTM
Interest3 Cr0.53 Cr0.28 CrSign in for TTM
Depreciation54 Cr54 Cr74 CrSign in for TTM
Profit before tax413 Cr495 Cr345 CrSign in for TTM
Tax %25.3%24.9%24.8%Sign in for TTM
Net profit308 Cr372 Cr259 CrSign in for TTM
EPS (₹)₹29.45₹35.52₹24.78Sign in for TTM
Dividend payout %23.2%24.6%43.2%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2024Mar 2025Mar 2026
Equity capital10 Cr10 Cr10 Cr
Reserves1,516 Cr1,802 Cr2,007 Cr
Borrowings6 Cr0.38 Cr—
Other liabilities168 Cr221 Cr220 Cr
Total liabilities1,701 Cr2,034 Cr2,235 Cr
Fixed assets (net)572 Cr792 Cr786 Cr
CWIP211 Cr50 Cr78 Cr
Investments246 Cr336 Cr491 Cr
Loans & advances0 Cr41 Cr0 Cr
Inventories208 Cr240 Cr326 Cr
Trade receivables350 Cr522 Cr460 Cr
Cash & bank15 Cr0.90 Cr12 Cr
Other assets99 Cr53 Cr81 Cr
Total assets1,701 Cr2,034 Cr2,235 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2024Mar 2025Mar 2026
Cash from operating activity265 Cr245 Cr267 Cr
Cash from investing-155 Cr-160 Cr-143 Cr
Cash from financing-99 Cr-99 Cr-113 Cr
Net cash flow12 Cr-14 Cr11 Cr
Free cash flow (OCF − Capex)180 Cr133 Cr172 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2024Mar 2025Mar 2026
ROCE %27.1%27.3%17.1%
ROE %20.2%20.5%12.9%
Debtor days125158159
Inventory days411330467
Days payable187156146
Cash conversion cycle350333480
Debt / equity0.00410.0002—
Current ratio6.306.177.39
Net debt / EBITDA-0.02-0.0010-0.03

Compare with peers

Loading peers…